1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2004A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysisJames, H.; Coller, J.; Gillis, D.; Bahnisch, J.; Sallustio, B.; Somogyi, A.
2007Pharmacogenetics of opioidsSomogyi, A.; Barratt, D.; Coller, J.
2004CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesHutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A.
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2007Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaInglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2007CYP2B6 CYP2D6 and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomesDavies, B.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.

Discover